| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Harlay Avocats #tech#startups#corporate#IP/IT#social#employment#tax Harlay Avocats (anciennement Kahn & Associés) est un cabinet d’avocats indépendant qui occupe depuis plus de vingt ans une place privilégiée dans le domaine du conseil aux entreprises de croissance et aux investisseurs dans les secteurs des technologies, de l’Internet, de l’e-commerce, des télécommunications, des sciences de la vie et des énergies renouvelables. La très bonne connaissance de ces secteurs d’activité permet au Cabinet d’être régulièrement sélectionné par les acteurs clés de ces domaines pour les assister lors de leurs opérations en France et à l’international. Le Cabinet conseille également les entreprises d’industries plus traditionnelles : presse et media, … | 8 | 0 | 7 | 39 |
 | Cancer Campus [Automatic translation follows] Cancer Campus is a research and innovation park that is developing in Villejuif (Val-de-Marne) Cancer Campus is a research and innovation park that is developing in Villejuif (Val-de-Marne), around Gustave Roussy, the leading cancer center in Europe. Its goal is to bring together all the talents (health professionals, researchers, students, companies) and citizens concerned by the disease to become an international reference site in health and cancer innovation. In this context, we are developing 3 programs dedicated to promoting entrepreneurship in oncology: - the Oncoentrepreneur program: tailor-made training and support set up for start-up projects in biotech, … Type: | 5 | 1 | 3 | 3 |
 | Paris Saclay Cancer Cluster (PSCC) Bringing together the actors of oncology innovation to develop solutions in France for the patients. As the first winner of the France 2030 NextGenerationEU program, the Paris Saclay Cancer Cluster (PSCC) is changing the pace of innovation in oncology to make it more predictive, precise, and efficient. 🚀 To accelerate this transformation, the French oncocluster is offering access to the best expertise, tools, and services for promising European researchers and developers, including mentors, networks, funding, data, samples, technologies, infrastructures, and laboratories. 🌟 This unique patient-driven ecosystem in the heart of Greater Paris, close to major French research, clinical, and innovation … Type: | 36 | 13 | 29 | 20 |
 | Option Finance Le media de référence des professionnels de la finance A PROPOS DU GROUPE OPTION FINANCE Avec ses différentes publications, le Groupe Option Finance est le seul groupe de presse à destination de l’ensemble des professionnels de la finance, de l'assurance et du droit des affaires. L’hebdomadaire Option Finance, se présente comme un véritable trait d’union entre les entreprises et la communauté financière depuis plus de 20 ans. Dédié à la présentation et l’analyse des grandes évolutions de la finance, aux innovations et montages financiers, aux problématiques de gestion des entreprises ainsi qu’à l’actualité de la communauté financière et de la … Type: | 143 | 48 | 119 | 59 |
 | Abzena Abzena is the leading end-to-end bioconjugate & complex biologics CDMO+CRO, focused on rapidly moving medicines forward. Abzena is the leading end-to-end bioconjugate, ADC, and complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor its strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule and move medicines forward faster. The company has research, … Type: | 7 | 0 | 1 | 446 |
 | Gradient Denervation Technologies Transforming the treatment of pulmonary hypertension A solution for patients suffering from heart failure with pulmonary hypertension. Type: | 1 | 1 | 0 | 14 |
 |  Moon Surgical Empowering the Surgeon Moon Surgical aims to augment the surgeon with leaps forward in computer vision, haptics, and robotics. medical device, minimally invasive surgery, digital surgery, comanipulation, AI, Machine Learning, Surgery, Laparoscopy, and Surgical Robotics Tags: FrenchTech120 FrenchTech2030 Type: | 16 | 8 | 8 | 78 |
 | EryPharm EryPharm is a biotech start-up company dedicated to the development and the operation of a large-scale process for the production of Red Blood Cells from stem cells. The technology has been developed by Dr. Luc Douay and his team at the Paris Sorbonne university. You can contact EryPharm through our website: http://erypharm.com/contact.html Or you can contact Loïc Tron directly: www.linkedin.com/in/loictron Type: | 9 | 1 | 8 | 4 |
 | SafeHeal Reshaping RecoveryTM Established in 2015 and based in France, SafeHealTM is a clinical stage medical device manufacturer. Specializing in the development of anastomosis protection devices for colorectal surgery, SafeHeal’s premier device, Colovac, was invented by French surgeon Charam Khosrovani to eliminate the need for diverting ostomies in patients undergoing colectomy. medical device Type: | 2 | 1 | 0 | 19 |
 | Acteurs de La French Care [Automatic translation follows] The grouping of actors who support and develop the health ecosystem in France! The grouping of actors who support and develop the health ecosystem in France! Type: | 36 | 6 | 34 | 1 |
 | Handelsblatt [Automatic translation follows] Germany's business and financial newspaper / Substance decides. The Handelsblatt is the largest business and financial newspaper in German. Around 200 editors and correspondents worldwide stand for well-founded and independent quality journalism that researches and analyzes national and global topics and events exclusively and up-to-date. With around 40 correspondents abroad, the Handelsblatt is on site in all economic centers of the world. News, business, stock exchange, economic policy, finance, and money Type: | 157 | 85 | 50 | 535 |
 | GENFIT Dedicated to improving the lives of patients with liver diseases characterized by high unmet medical needs. GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases characterized by high unmet medical needs. GENFIT is a pioneer in liver disease research and development with a rich history and strong scientific heritage spanning more than two decades. Its capacity to develop high potential assets, from early-stages to late development and pre-commercialization stages, is illustrated through the successful 52-week readout of its Phase 3 trial (ELATIVE®) evaluating elafibranor in Primary Biliary Cholangitis (PBC). Today, … Type: | 10 | 5 | 5 | 190 |
 | Varenne Capital Partners Varenne Capital Partners is a Paris-based, process-driven, global investment manager whose purpose is to deliver superior long-term returns with the minimum necessary risk-taking. We strive to achieve this goal by employing proprietary research and combining complementary investment frameworks in a single strategy: Long Equity, Short Equity, Merger Arbitrage and Tail Risk Hedging. Our ‘brokers are not welcome’ policy means that we rely exclusively on our own internal research and base our analysis on facts and figures. All of our investment frameworks stem from years of research and development and as a result comprise original methodologies, formalized processes, dedicated teams of … Type: | 6 | 3 | 1 | 40 |
 |  Kymab Ltd Kymab, a Sanofi company, based in Cambridge UK, is working to provide novel solutions in drug and vaccine development. Kymab, a Sanofi company, is a clinical-stage global biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary antibody platform which contains a full diversity of human antibodies, making it the most comprehensive antibody development platform available. Kymab’s platform has been designed to maximise the diversity of human antibodies produced in response to immunisation with antigens. Selecting from a broad diversity of fully human antibodies assures the highest probability of finding drug candidates with … Type: | 4 | 1 | 0 | 39 |
 | Quantum Surgical Standardize minimally invasive cancer treatment Quantum Surgical is a French company founded in Montpellier, France, speacialized in medical robotics and AI. Its Epione® robotic percutaneous ablation platform is dedicated to the curative and early treatment of cancers. Quantum Surgical thus offers a new approach to cancer treatment by standardizing access to care. More patients can benefit from innovative, better targeted and less invasive treatments. Hundreds of patients have already been treated worldwide. Co-founded in 2017 and with a team of 110+ employees, Quantum Surgical is based in Montpellier, with offices in Miami, Florida. Quantum Surgical received the Prix Galien USA … Tags: FrenchTech2030 Type: | 43 | 12 | 36 | 119 |
 | Inotrem Control innate immunity Inotrem is a biotechnology company specialized in immunotherapy for acute inflammatory syndromes, such as septic shock. Founded in 2013, with offices in Paris and a technology center in Nancy (France), the company has developed a new concept of immunomodulation that targets the TREM-1 pathway to control unbalanced inflammatory responses. Leveraging its proprietary technology platform, Inotrem has developed the first-in-class TREM-1 inhibitor, nangibotide, with applications in a number of therapeutic indications such as septic shock or myocardial infarction. Next to acute inflammatory syndromes, Inotrem is also developing a program targeting chronic inflammatory diseases. Type: | 7 | 6 | 1 | 33 |
 | Abivax Abivax is a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Abivax is currently evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. Abivax also plans to initiate a Phase 2a clinical trial of obefazimod in patients with Crohn’s disease. Obefazimod is an investigational, orally administered, once-daily therapy, which we believe has the potential to be a differentiated treatment option for inflammatory bowel diseases. It is the first and only molecule … Type: | 9 | 5 | 5 | 81 |
 | Octarine Bio We're harnessing nature to drive sustainable solutions Pioneering new sustainable bio-based ingredients Synthetic Biology, Fermentation, Yeast metabolism, Plant metabolism, and Metabolic engineering Type: | 1 | 1 | 0 | 27 |
 | ImmuONE Specialised translational approaches and in vitro testing services ImmuONE specialises in human alveolar macrophage responses, epithelial cell culture platforms and testing services. Our respiratory tissue models closely resemble lung physiology to provide relevant, reliable, and reproducible results. ImmuONE is partnered with the industry and academia to develop sustainable technologies for the future to support human-relevant, mechanistic driven safety assessments and develop animal product-free cell models. We offer a range of standard and bespoke assessments for inhalation safety assessment needs. ImmuONE provides innovative solutions for inhalation toxicology, irritation sensitization, alveolar clearance, inflammation and can tailor to your inhalation safety assessment needs. … Type: | 4 | 0 | 3 | 15 |
 | Esquire magazine The most stylish and substantial men’s magazine. A one-stop shop for lifestyle advice – cars, culture, grooming, gadgets, food, fashion and more – and a showcase for brilliant journalism and photography. Esquire is intelligent, irreverent and unapologetically masculine. Type: | 17 | 11 | 12 | 292 |
 | Corriere della Sera [Automatic translation follows] Official profile of Corriere della Sera Founded in 1876, Corriere della Sera is the most widely read Italian newspaper. Deeply rooted in the political, economic and cultural tradition of the country, it is an international point of reference and is considered the most authoritative, for the completeness, depth and quality of the information provided. Type: | 74 | 23 | 34 | 1,033 |
 | LSI We help Medtech and Healthtech executives build lasting businesses, across the globe 📈 LSI’s ecosystem provides the intelligence and relationships Medtech leaders need to build breakthrough businesses. We support thousands of innovators, investors, and strategics around the world working to move Medtech forward, together. For nearly two decades, our market intelligence solutions have powered strategic decisions for the world’s most successful Medtech, Life Science, and Healthcare organizations. With that foundation, we launched the LSI Emerging Medtech Summits with one vision: create forums for the leaders building, financing, and scaling Medtech innovation to challenge convention and catalyze better healthcare for all. … Type: | 32 | 1 | 32 | 62 |
 | Antler Your drive and ambition should be able to change the world. Antler is one of the most active early-stage investors globally. The firm leads in ‘Day Zero’ investing, an approach to venture capital focused on partnering with founders pre-launch. Antler systematically removes capital and network constraints for early-stage technology entrepreneurs by providing co-founder matching, deep business model validation, initial capital, expansion support, and follow-on funding. The firm is present in 30 cities across most leading technology ecosystems globally and has made over 1,300 investments into early-stage startups. Antler has been repeatedly recognized by Pitchbook as the world’s most active angel … Type: | 84 | 40 | 50 | 2,170 |
 | Quest for health [Automatic translation follows] Healthcare accelerator in the heart of Europe. For biotech, medtech and digital health startups. Quest for health is the Grand Est incubator dedicated to healthcare start-ups at the European level. Born from the initiative of the Quest for change incubator network (located in Reims, Strasbourg, Metz, Charleville-Mézières, Epinal and Mulhouse), the incubator supports more than sixty biotech, medtech and e-health start-ups. Quest for health is positioned as the leading national player in this field. Among the supported start-ups, 21 are winners of the national i-Lab competition (including four grand prizes), five of the i-Nov competition and two … Type: | 43 | 12 | 41 | 8 |
 | Groupe Stratos Groupe STRATOS is an entrepreneurs community providing companies with custom-made solutions. Groupe STRATOS is an entrepreneurs community providing companies with custom-made solutions. Our community is composed of entrepreneurs with expertise on a specific topic and each single member is/was an entrepreneur. Groupe STRATOS was founded in 2020 with the merger of 2 other companies created 10 & 20 years ago. About our advisory activiy : - Fund raisings through our network of +1 000 investors (France & International) - Mergers & Acquisitions - Financial audits (M&A, valuation of companies, due diligence...) - Financial analysis - Strategy & business development - … Type: | 61 | 2 | 61 | 7 |
 | France Deeptech [Automatic translation follows] When science undertakes The community that brings together deeptech players for an entrepreneurial, collective and scientific response to our contemporary challenges Type: | 58 | 18 | 50 | 4 |
 | IMS (Institut du Médicament de Strasbourg) [Automatic translation follows] Interdisciplinary Thematic Institute of the University of Strasbourg The Strasbourg Institute of Medicines meets the challenges of the medicine sector: producing cutting-edge research up to the pre-clinical stage, promoting technological innovation through the creation of start-ups and training the new generation of researchers in the management of medicine innovation. Type: | 17 | 2 | 8 | 8 |
 | HealthTech For Care An endowment fund to support and promote access to care for all patients as well as new medical and drug technologies. The HealthTech For Care endowment fund has three essential missions: - fostering the growth and development of the entire health ecosystem, - advocating for the advancement of innovative therapies and treatments to benefit patients, - promoting enhanced access to care for patients within the European healthcare ecosystem. Health Type: | 30 | 14 | 24 | 7 |
 | Private Equity Magazine [Automatic translation follows] The monthly publication for private equity professionals Find the latest news for private equity professionals on our website and magazine. Deals, surveys and analyses, with a cumulative audience of over 30,000 readers, Private Equity Magazine has become the reference publication for French and European private equity players for 10 years. Type: | 86 | 21 | 80 | 9 |
 | OncoSTART [Automatic translation follows] Undertaking against cancer OncoSTART is a multi-partner program specifically aimed at encouraging & boosting the creation of companies in cancerology through a continuum of actions dedicated to training and support, bringing together as many players as possible working in the field of the fight against cancer to demonstrate a dynamic sector recognized nationally and internationally. Program divided into 3 types of actions covering the entire innovation value chain: o Awareness: raise awareness, throughout the national territory, among aspiring entrepreneurs (doctoral students, young researchers, researchers) in the field of oncology; o Training: offer a training offer to motivated … Type: | 19 | 5 | 10 | 1 |
 | CorWave CorWave develops and manufactures innovative implantable blood pumps based on a breakthrough membrane technology. CorWave is a French company developing innovative cardiac assist devices. CorWave’s wave membrane pump is a breakthrough technology that differs from today’s commercially available left ventricular assist devices (LVADs) by its physiological operation, designed to mimic a pulse and blood flow rates similar to those of a healthy heart. Ultimately, CorWave’s membrane pump technology is expected to reduce the complications associated with current devices and improve the management of heart failure patients. A member of the French Tech 120, CorWave was founded in 2012 by start-up … Tags: FrenchTech120 Type: | 31 | 17 | 23 | 100 |
 | Bon Vivant Animal-free dairy proteins, for a sustainable future. We are a French biotechnology company developing cutting-edge precision fermentation techniques, dedicated to take part in the environmental transition within the dairy production sector. Our innovative technology enables the production of dairy proteins without the need for animals, significantly reducing the ecological footprint. By providing our clients with cutting-edge, sustainable ingredients, we empower them to create a diverse range of dairy products identical to those you already love, both environmentally conscious and nutritionally rich. Join us on our journey to shaping a future where ethical dairy alternatives are complementary to conventional farming and … Type: | 51 | 12 | 40 | 111 |
 | Predict4Health AI-powered Precision Medicine for Organ Failure Our mission is to improve patients’ live and healthcare systems by postponing organ failure with the power of AI. 💪 Our products : 📊 A Decision making tool based on iBox : Predigraft helps physicians monitor transplanted patients by providing allograft survival prognosis. 📱 A Smart telemonitoring of chronic patients : Apilife is a fully connected platform acting as a medical hub for patients and their medical teams. 🧬 A Digital Biomarker for clinical trials : Our technology can be used to design clinical trials and to assess kidney allograft survival. Medicine, Machine Learning, … Type: | 48 | 7 | 36 | 26 |
 | PEAK LIFECYCLES HR - Europe & the US Beyond the people you want, get the people you need PEAK LIFECYCLES HR is an international Executive Search and Talent Management company dedicated to Global "Care environment" markets and their stakeholders. Placing the analysis of the business life cycle, and that of products, skills, and projects at the heart of its activity, Peak Lifecycles' unique, innovative expertise is founded on its anticipation of market requirements. OUR OFFERS: Executive Search, Talent Management, Organizational audit, Executive Coaching We also developed an offer dedicated to Startups and their lifecycles. Executive Search, Talent Management, Life Sciences, Market Access, Medical, Business Operation, Digital , Food, … Type: | 25 | 0 | 23 | 12 |
 | GIMLI Leverage Real World Evidence in oncology Gimli empowers medical professionals to structure medical data. We extract and structure data directly from the EMR to streamline RWD, allowing the generation of strong RWE. Ask us for a demo! Gimli is a Startup working with university hospitals, pharmaceutical companies, data analytics providers, and startups. Type: | 29 | 2 | 11 | 6 |
 | AstronauTx AstronauTx is tackling dementia through improving brain physiology AstronauTx is at the forefront of a novel approach to treating neurodegenerative diseases. We have a unique portfolio of small-molecule therapeutics to restore dysregulated physiology to both improve symptoms and modify disease. Type: | 2 | 0 | 1 | 14 |
 | World Economic Forum The World Economic Forum is the International Organization for Public-Private Cooperation. We are the international institution for public private cooperation. We connect communities of leaders around global issues through high-level meetings, research, initiatives and digital networks. We are non-profit, impartial and independent. We believe dialogue and cooperation between business, government and civil society can improve the state of the world. Tags: H2020 Type: | 310 | 213 | 112 | 5,002 |
 | Business Insider What you want to know. Follow us on Facebook, Instagram, YouTube, and TikTok. Visit our homepage for the day's top stories. Type: | 250 | 154 | 100 | 11 |
 | Zambon Since 1906 our mission is innovating Cure & Care to make patients’ lives better. Zambon is a chemical-pharmaceutical company founded on the history and values of an Italian family and committed to innovating cure & care to improve patients’ lives. Present in Europe, America and Asia with over 2,900 employees and manufacturing units in Italy, Switzerland, France, China and Brazil, in 2023 the Group revenues amounted to 899 million euros. Zambon SpA, the pharma subsidiary of the group with its 23 branchess and products commercialized in 87 countries, has taken a new role in the industry. In addition to pain … Type: | 16 | 4 | 8 | 2,465 |
 | Les Echos [Automatic translation follows] Find on LesEchos.fr all the economic and financial news in France and around the world, discover exclusive analyses, special reports, analyses, columns and large formats. http://www.lesechos.fr/ Type: | 631 | 445 | 232 | 1 |
 | Palais de Tokyo [Automatic translation follows] Contemporary art center, Paris📍 With its 22,000 m2, the Palais de Tokyo stands out with its energy as one of the largest contemporary art centers in Europe. It encourages contemporary creation with an eclectic and inventive program around emerging and established artists from all backgrounds. contemporary art, exhibitions, performances, and concerts Type: | 34 | 22 | 9 | 166 |
 | Rothschild & Co Rothschild & Co is one of the world's largest independent financial advisory groups. We offer a distinct perspective that makes a meaningful difference to our clients’ business and wealth. With a team of 4,200 talented financial services specialists on the ground in more than 40 countries across the world, we provide independent advice on M&A, strategy and financing, as well as investment and wealth management solutions to large institutions, families, individuals and governments. As a family-controlled business that has been at the centre of the world’s financial markets for over 200 years, we can rely on an unrivalled network of … Type: | 36 | 22 | 8 | 5,523 |
 | Pyrowave Electrifying progress. We are leading the revolution in #sustainable #greenchemistry by offering a modular microwave based technology that can #unzip waste plastics back to their root chemical form. Styrene, Polyolefin wax, Lubricants, Microwave, Plastics, #CircularEconomy, #LowCarbonCement , CleanTechnology, #Nanorecycling, GreenSolutions, and #WasteReduction Type: | 10 | 6 | 6 | 11 |
 | Enersens Enersens produces the best thermal barriers and additives to improve safety, energy efficiency and flame protection Enersens is a leading innovative company specializing in silica aerogel products. We develop and market high performance aerogel-based insulation materials. We aim to become the leader in these high performance materials to enable our customers and partners to achieve their own goals around global trends in energy efficiency, sustainability, electric mobility and clean energy. Our Skogar® products solve the thermal runaway problems of batteries for any type of electric vehicle or electric mobility. Their performance and finesse also make it possible to solve many … Type: | 34 | 5 | 32 | 8 |
 | HighLife Trans-septal Mitral Valve Replacement HighLife is a trans-catheter mitral valve replacement company committed to bringing the best minimally invasive technology to the patients. | 5 | 2 | 1 | 72 |
 | TISSIUM Biomorphic Programmable Polymers TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function. Since the discovery of our first polymer at the labs of Bob Langer and Jeff Karp at MIT, we recognized the exceptional potential for our technology to revolutionize the field of tissue reconstruction in multiple therapeutic areas. Our unique approach to product development leverages the knowledge gained from the development of our technology platform comprised of proprietary polymers, activation technologies, and delivery devices. We have developed a fully … Tags: FrenchTech120 Type: | 17 | 11 | 6 | 126 |
 | BionomeeX BionomeeX provides innovative analysis tools to support your biological, medical and environmental R&D projects. BionomeeX is a CNRS, and Univ. Montpellier spin off company. Our solutions include, at the same time, crafted algorithms and/or adapted computational solutions in a single package following your needs and demands. We also deploy our own software initially brewed in the academic world to provide solutions in biology, genetics, genomics... Biology, AI, and DeepLearning Type: | 14 | 1 | 4 | 6 |
 | Adjuvant Capital Adjuvant Capital is the leading investment fund focused on public health. Adjuvant Capital is a life sciences investment firm focused on global health. We make $10-$25 million investments in ambitious companies targeting opportunities in high burden and neglected disease. Type: | 6 | 0 | 7 | 15 |
 | Numbered We are a design and technology agency crafting beautiful digital experiences and products Contact@numbered.com Numbered is an awards winning creative agency working with fashion, tech & lifestyle brands. We collaborate closely with our clients to tell their stories, engaging audiences by building beautiful experiences & products. Based in Amsterdam & New-york. We strongly believe every brand and project is unique and should be tailor-made from industry leaders to early stage companies. We don’t do one size fits all. Collaborating with international brands, founders, start-ups, venture capitals, and more – producing, results-driven, unique products and experiences from conception to delivery. With … Type: | 4 | 0 | 4 | 40 |
 | GAE Conseil [Automatic translation follows] Expert in the prevention of addictive practices in professional environments: advice, awareness, training, etc. G.A.E Conseil, the leading player in the prevention of addictive practices at work. Founded in 2014, GAE Conseil is an independent consulting firm specializing in the prevention of addictive practices in professional environments (psychoactive products and behavioral addictions). Around the firm's partners and the managers of the various centers of expertise (Audit and Consulting Center, Training Center, Center for Assistance to Employees in Difficulty), the GAE Conseil teams support private and public companies of all sizes and from all sectors of activity in … Type: | 53 | 1 | 52 | 41 |
 | M&M Conseil [Automatic translation follows] Public Affairs - Institutional Relations M&M Conseil has specialized in the organization of institutional events and in public affairs consulting for over 25 years. Working closely with French and European institutions, we organize key meetings between public, private and institutional stakeholders. Public Affairs Consulting, Institutional Communication, Events, and Public Relations Type: | 102 | 8 | 99 | 8 |
 |  Mablink Bioscience Transforming cancer immunotherapy with next generation ADCs Mablink Bioscience is a French biotechnology company that is actively involved in the fight against cancer by bringing disruptive therapeutic solutions. With its Antibody-Drug Conjugates (ADC) masking technology, Mablink Bioscience aims to dramatically improve the efficiency of ADC therapies and accelerate the development of new treatments. Based in Lyon, where it is developing an unprecedented innovation center, Mablink currently has around 30 employees with diverse backgrounds. biotechnology, drug development, drug discovery, oncology, and R&D Type: | 15 | 9 | 10 | 35 |
 | GLEAMER Medical-Grade AI for Radiology GLEAMER offers a suite of AI solutions for radiology that encapsulate medical-grade expertise. Our company wants to support imaging readers to secure diagnoses for all patients at all times while improving comfort and workflow efficiency. Our team imagines and develops solutions booth at the level of an expert and is easy to integrate thanks to the joint work of a multi-disciplinary team encapsulating AI and radiologist experts. GLEAMER has already been integrated into more than 2.000 institutions in each part of the world. 🏅Alexander Margulis award - Scientific excellence for the BoneView clinical study 🏅 🏅 … Type: | 24 | 10 | 16 | 84 |
 | PE Cube You're Good, get Better. PE Cube is a SaaS solution for each team member of Private Equity management companies to optimize fund management’s performance and Investor Relation while enabling a rich, reliable and transparent communication towards each of its stakeholders. PE Cube is based on 20 years of Private Equity practice and on the key-belief that data is crucial to each level of fund management. This is why PECube is designed to ensure flawless end-to-end processing to express the full potential for monitoring and steering fund management activity. Each general partner member is thus equipped to ensure reliability, security and … Type: | 44 | 4 | 44 | 13 |
 | VERTEXA Digital Therapeutics [Automatic translation follows] VERTEXA is an immersive therapeutic game in virtual reality. Let's digitalize health! The VERTEXA digital therapy (Virtual Reality Therapy Exposition in Anorexia) aims to use virtual reality as a support tool in the form of a gamified and immersive psychoeducational journey for patients suffering from eating disorders (anorexia, bulimia). The use of digital tools and new technologies now allow an innovative, personalized, motivating and accessible approach regardless of where our patients are treated. The VERTEXA tool is intended to be autonomous: the patient is an actor in their care. They will be immersed in a soothing universe, … Type: | 23 | 2 | 23 | 2 |
 | CNBC Welcome to CNBC's home on LinkedIn! Follow us for regular updates about financial news, top CNBC.com stories, behind-the-scenes moments and more. CNBC, Inc. provides business news in the United States and Canada. It provides real-time financial market coverage and business information. The company, through its Web site, cnbc.com, provides real-time market analysis; video programming daily; industry and topic-specific blogs; cnbc.com live stream, a long-form scheduled programming of events; charts; and investing tools. The company was founded in 1989 and is headquartered in Englewood Cliffs, New Jersey. CNBC, Inc. operates as a subsidiary of NBC Universal, Inc. Financial News, Stocks, Market … Type: | 369 | 263 | 198 | 3,003 |
 | Sightline Climate (CTVC) Bringing clarity to the new climate economy Sightline Climate is the market intelligence platform bringing clarity to the new climate economy. Built on the foundation of the CTVC newsletter, Sightline Climate’s subscription intelligence product provides data, tools, and frameworks to help investors, corporates, and governments build and finance the new climate economy. Explore Sightline Climate: https://www.sightlineclimate.com/ CTVC is the industry-leading free newsletter powered by Sightline Climate. Join the community of 60,000 climate leaders. Subscribe: https://www.ctvc.co/ Type: | 80 | 8 | 75 | 34 |
 | TAC ECONOMICS An independent European research group providing advisory services on international economic and financial issues TAC ECONOMICS is a French independent leading provider of economic and financial consulting services with a strong expertise on country risk based on AI and data-driven solutions. Our team of experienced economists and data scientists specializes in providing cutting-edge data, models, and analysis to help our clients detect major risks and evaluate investment opportunities. Our commitment to AI and data-driven solutions is rooted in our pioneering work in the early 1990s, where we developed artificial intelligence tools to predict financial crises in emerging economies and prevent … | 11 | 3 | 5 | 13 |
 | Owkin We use AI to find the right treatment for every patient. Owkin is an AI biotechnology company that uses AI to find the right treatment for every patient. We combine the best of human and artificial intelligence to answer the research questions shared by biopharma and academic researchers. By closing the translational gap between complex biology and new treatments, we bring new diagnostics and drugs to patients sooner. We use AI to identify new treatments, de-risk and accelerate clinical trials and build diagnostic tools. Using federated learning, a pioneering collaborative AI framework, Owkin enables partners to unlock valuable insights from … Type: | 72 | 34 | 43 | 474 |
 | Micropep Technologies Micropep is an innovative plant biotechnology company developing the next generation of biological crop protection solutions based on the incredible potential of micropeptides; short natural peptide molecules that target and regulate plant genes and proteins. Type: | 19 | 11 | 6 | 57 |
 | SWAP Food Formerly Umiami | The tender, juicy whole filet made from plants. We make delicious, clean-label meat replacements from plants. Our first product, SWAP Filet (SWAP Chicken in the United States) is a thick, whole filet that closely replicates the taste, texture and appearance of chicken using a short list of familiar ingredients. From preparation to performance, SWAP Filet can replace chicken on any menu, enabling chefs to recreate classic recipes for modern times. Originally founded in France in 2020, we rebranded from Umiami to SWAP in 2024 to convey how simple it is for consumers and chefs to swap protein. … Tags: FrenchTech120 FrenchTech2030 Type: | 39 | 21 | 24 | 105 |
 | Home Biosciences A new breed of biotech company A new breed of biotech company aiming to unlock scientific breakthrough by leveraging an asset-centric operating model Type: | 10 | 5 | 6 | 7 |
 | Microphyt Fostering a Blue Future ! Created in 2007 near Montpellier-France, Microphyt develops and markets unique microalgae-based bioactives using breakthrough technologies and processes. Developed over 10 years, and endorsed by key customers, partners and investors, these bioactives are addressing the nutraceutical & cosmetic industry sectors. photobioreactor, microalgae, nutrition, biotechnology, Blue Future, nutraceuticals, Made in France, Cosmetics, innovation, better living, patented technology, natural ingredients, and bioactive compounds Type: | 30 | 14 | 14 | 62 |
 | GenSight Biologics Applying pathbreaking science to transform the lives of patients with severe retinal neurodegenerative diseases GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. GenSight Biologics’ pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence (MTS) and optogenetics for retinitis pigmentosa, to help preserve or restore vision in patients suffering from severe degenerative retinal diseases. GenSight Biologics’ lead product candidate, GS010, is in Phase III trials in Leber’s Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible low vision and legal blindness in … Type: | 16 | 6 | 11 | 38 |
 | AFI Ventures Europe’s Day-One Impact Launchpad At AFI Ventures, we are committed to backing the most promising seed & pre-seed impact entrepreneurs. From climate action to healthy living, we partner with every visionary that shares the ambition of deep, at-scale impact. We are investing up to 500k€ in 1 to 2 companies every month. AFI Ventures is the seed fund of Alliance for Impact, Europe's day one impact launchpad. impactinvesting, capitalrisque, VC, impact, startup, fonds, seed, financement, entrepreneurship, and socialbusiness Type: | 18 | 15 | 4 | 6 |
 | Idéal investisseur - Magazine [Automatic translation follows] Investment magazine - investments. Specialized investment and investments magazine. We talk about finance, economics, entrepreneurship, real estate... Nearly 3 million visits in 2023 and on newsstands from fall 2024. Advertising agency: Kétil Media 2023: Nominated for the Plumes d'or et d'argent de l'économie et du droit prize for the article "ISR: "responsible" SCPIs are more efficient, but..." 2022: Nominated for the article prize by MédiaPro (formerly Presse Pro), an association for the promotion of professional information for the article "GameStop: when amateur traders shake the financial system" Real estate, personal finance, finance, stock market, life insurance, savings, … Type: | 12 | 2 | 5 | 7 |
 | Ulysse Communication [Automatic translation follows] Who better than former journalists to make your voice heard? Ulysse Communication, at the crossroads of the press and communication. Specialized in press relations and financial communication, Ulysse Communication was created by former economic and financial journalists who themselves surrounded themselves with former journalists. The agency and the team are strongly marked by this DNA which translates into an intimate knowledge of the media, an ability to develop tailor-made messages and a good understanding of the economic and business world. Press relations, Financial communication, Finance, Listed company, IPO, Financial operations, Public relations, Corporate communication, Asset management, Real … Type: | 58 | 1 | 56 | 15 |
 | Startup Insider [Automatic translation follows] The most important news, trends and investments from the German startup scene. Startup Insider is a new industry portal for the startup scene in Germany, Austria and Switzerland. Here you will find news from all regions and industries as well as an overview of the most important players and events in the German-speaking startup world. The mission of Startup Insider is to support startups on their way to success. We help startups and grownups to establish contacts with investors and customers, to find new employees or through media visibility at events or online, in print or newsletters. … Type: | 42 | 5 | 40 | 40 |
 | Cyber Valley Europe’s largest and leading center for excellence in artificial intelligence and modern robotics. Cyber Valley is Europe’s largest and leading research consortium in the field of artificial intelligence (AI) and modern robotics. Cyber Valley has a mission and a public mandate to advocate for entrepreneurship, research, development, application, and acceptance of technologies and methods in the field of intelligent systems. The company envisions a future where the full potential of intelligent systems is leveraged for the greater good of the world. The Cyber Valley Community connects partners from science, industry, and society, along with AI researchers and entrepreneurs. The Cyber … Type: | 13 | 1 | 9 | 28 |
 | Intermediate Capital Group (ICG) Global alternative asset manager, creating sustainable value by partnering with ambitious businesses. We are a global alternative asset manager with a 35-year track record. We are driven by purpose and sustainable results. We deliver outstanding investment performance to our clients, provide wide‐ranging capital solutions for corporates and owners of real assets, and create value for stakeholders, shareholders and communities. Private Markets, Private Capital, Alternative Asset Management, Private Credit, Private Debt, Secondaries, Structured Products, Real Assets, Infrastructure, Real Estate, and Life Sciences Type: | 12 | 3 | 5 | 793 |
 | Forbion Impacting the future of medicine Forbion was born out of ABN AMRO Capital Life Sciences in 2000. Six years later, we transitioned to Forbion Capital Partners. Today, to emphasize our value-add beyond merely providing capital, we are simply known as Forbion. For more than two decades, our investment team has built an impressive track record of sourcing, building and guiding life-sciences companies resulting in many breakthrough therapies and valuable exits. Forbion currently manages over €2.3 bn across ten funds. As of October 2022, Forbion holds 43 active portfolio companies bringing its investments to 95 companies to date with 46 employees. … Type: | 9 | 4 | 6 | 68 |
 | Apollo Global Management, Inc. Apollo is a high-growth alternative asset manager. Apollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade credit to private equity. For more than three decades, our investing expertise across our fully integrated platform has served the financial return needs of our clients and provided businesses with innovative capital solutions for growth. Through Athene, our retirement services business, we specialize in helping clients achieve financial security by providing a suite of retirement savings products and acting as a solutions … Type: | 23 | 4 | 9 | 4,313 |
 | STAT Reporting from the frontiers of health and medicine. Reporting from the frontiers of health and medicine We take you inside the science labs and hospitals, biotech boardrooms and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health. These are the stories that matter to us all. Get access to exclusive content: http://www.statnews.com. Follow us on Twitter @statnews and on Facebook at facebook.com/statnews news, science news, medicine, health, biotech, pharma, health tech, covid, hospitals, and … Type: | 46 | 16 | 24 | 336 |
 | Salesforce Ventures For the most enterprising founders. Salesforce Ventures helps enterprising founders build companies that reinvent the way the world works. Since 2009, we’ve invested in and partnered with more than 400 of the world's most tenacious enterprise software companies from seed to IPO, including Airtable, Databricks, DocuSign, Guild Education, Hopin, monday.com, nCino, Snowflake, Snyk, Stripe, Tanium, and Zoom. Salesforce Ventures leverages our decades of expertise in the cloud and our long-term relationships with key decision-makers at thousands of businesses around the world to give our portfolio companies an unfair advantage, help them build credibility, and accelerate growth. Cloud Computing, SaaS, Enterprise … Type: | 10 | 4 | 4 | 67 |
 | MSInsight Unlocking the Power of Genomics: Advancing Cancer Care and Precision Medicine MSInsight, a French health-tech company, empowers the fight against cancer by revealing actionable information from the genome. We are committed to developing a portfolio of state-of-the-art diagnostic solutions for Microsatellite Instability (MSI) status. MSI has been shown to be an indicator of treatment response, especially for immune checkpoint inhibitors, and as an important pan-cancer biomarker. We aim to propose bioinformatic tools for delivering insights on microsatellite mutational variations using Next-Generation Sequencing (NGS) data. Our flagship product, MSIcare, will be available as a robust diagnostic, prognostic, and theranostic assistant for … Type: | 36 | 6 | 35 | 8 |
 | BrightHeart Advancing prenatal ultrasound screening with AI At BrightHeart, we believe every single fetal ultrasound screening exam should be performed with the highest level of accuracy, so each mother and baby receive the highest possible quality of care. Type: | 2 | 2 | 1 | 10 |
 | VITAL MEAT Sustainable, healthy and delicious cultivated meat 🌎🍴 VITAL MEAT is a cultivated meat start-up based out of Nantes, France 🇫🇷 Our mission is to reduce human impact on the environment by providing HEALTHY, DELICIOUS, ETHICAL and SUSTAINABLE meat to billions of people 🌎 Thanks to our scalable technology and a cost effective process, we are gearing up to commercialize our first chicken product 🐔! Type: | 15 | 5 | 11 | 12 |
 | baby vc Come for a VC bootcamp, stay for the community. First bootcamp for those who aspire to join the venture capital community. A unique program during which a group of aspiring VCs meet those who make venture capital. They reveal to us behind the scenes, the secrets and the future of their profession. Have a look at our job board juste here: [https://airtable.com/shrePuJCHfJbTq17m/tblsaFTVJnUA2JWuY] Are you a venture capital fund or startup looking for a stellar addition to your team? Then add your job offer via this form [https://airtable.com/shrYcgd6zU6VAKlRL] to get access to our fellows and our community 🤓 venture capital, bootcamp, … Type: | 76 | 4 | 73 | 210 |
 | Northzone Northzone is a venture capital fund shaped by lives as entrepreneurs and investors. Founded in 1996. Northzone is a technology investment partnership. With two decades of experience, we have been chosen by some of the best entrepreneurs as their long-term partner for growth. With offices across the Nordics, London and in New York, we work around the clock to connect our companies with customers, business partners and key talent on a truly international scale. As former entrepreneurs ourselves, we have been sat on both sides of the table, and place the relationships with our Founders at the core of our … Type: | 54 | 18 | 38 | 59 |
 | Merieux Equity Partners Invested Investors Merieux Equity Partners is a multistage investment manager specialized in the healthcare & nutrition sectors via two dedicated platforms: Venture and Growth/Buyout. As an independent General Partner - registered under the French Financial Markets Authority AMF ("Autorité des Marchés Financiers") - Merieux Equity Partners currently manages 5 main funds, representing more than €1 billion of Commitments, and has supported over 45 companies in Europe and North America since its creation - in Venture Capital and Growth/Buyout. Our passion is to work alongside entrepreneurs and companies with an ambitious growth plan, offering them privileged access to our sector-expertise and … Type: | 11 | 9 | 5 | 38 |
 | Algorithmiq We develop advanced quantum algorithms to solve complex problems in life sciences Algorithmiq is a company developing advanced algorithms to solve complex problems in life sciences. Our mission is to revolutionise life sciences by exploiting the potential of quantum computing to solve currently inaccessible problems. We combine our expertise in quantum information, complex systems, and computational physics to develop algorithms that run on near-term quantum devices to discover new drugs and develop new materials Quantum physics, Complex networks, Quantum computing, Quantum simulations, Quantum chemistry, Quantum software, and Computational physics Type: | 13 | 0 | 13 | 40 |
 | LimFlow SA Providing minimally-invasive options for the treatment of end-stage chronic limb-threatening ischemia (CLTI) LimFlow SA, part of Inari Medical, Inc., is a leading provider of medical technology that provides new hope to patients suffering from the most severe form of peripheral artery disease, Chronic Limb-Threatening Ischemia (CLTI), and who are facing the prospect of amputation. LimFlow is revolutionizing healthcare by offering a breakthrough solution for end-stage CLTI patients when traditional treatments fall short. Using an innovative percutaneous procedure, the LimFlow System reinvents anatomy to restore blood flow to the ischemic foot, which aims to alleviate pain, foster wound healing, reduce amputations … Type: | 1 | 1 | 0 | 29 |
 | Inventiva Pharma A clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies. Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical need in the areas of fibrosis, lysosomal storage disorders and oncology. Our research and development programs target indications with substantial unmet medical needs: NASH, MPS and oncology. Drug Discovery, Biotech, Oncology, Fibrosis, Lysosomal Storage Disorders, NASH, and SSc Type: | 4 | 1 | 1 | 114 |
 | Niryo Niryo is a French startup designing collaborative #robots for universities, engineering schools, R&D & training centers. Niryo is a French startup designing desktop collaborative #robots for universities, engineering schools, training centers and research centers. Its reality? Democratizing cobotics and allowing its accessibility, while promoting a new vision for industry tinted with reason, humanity, durability and resilience. To keep on materializing this ambition, a team of forty passionate develop cutting edge hardware and software. This way, professionals are free to automate, research and train without a hassle. Embeddable in a variety of ecosystems, Niryo's cobots promote the awareness of a world … Type: | 49 | 10 | 17 | 48 |
 | Invyo Europe's leading data platform for data-driven investors (Venture Capital / Private Equity / Family Office) Since 2018, INVYO has been the trusted partner for investors in private equity, venture capital and family offices. We are a reference platform in Europe, propelling investors towards a data and tech-driven investment model thanks to AI. Our sector expertise harnesses your data to boost your human and financial performance. - French publisher - More than 50 client funds - 16 data experts - 2 offices: Paris & Madrid - SaaS solutions Our mission : At INVYO, we unleash the potential of investment teams through … Type: | 79 | 6 | 74 | 22 |
 | Kiro Artificial intelligence serving clinical biology Kiro is a fast-moving startup developing solutions for better patient care, powered by artificial intelligence. We aim at improving everyone’s health by supporting patients and doctors with understandable and relevant information. We believe that medical biology is at the heart of healthcare. It contributes greatly to the diagnosis, treatment and prevention of diseases. Our mission is to foster the interactions between laboratories, health professionals and patients, to go beyond results in patient care thanks to new technologies and artificial intelligence. Since its inception, Kiro has worked in close partnership with clinical biologists, doctors and medical … Tags: FrenchTech2030 Type: | 46 | 11 | 23 | 59 |
 | Interaction Healthcare [Automatic translation follows] Your strategy deserves the best treatment 100% digital agency specializing in the health sector. Founded in 2008, Interaction Healthcare's expertise is based on 4 pillars: - digital strategy consulting; - web and social media solutions; - mobile solutions and new interfaces; - digital medical simulation and serious game. Interaction Healthcare designs and develops digital communication and e-learning tools for the pharmaceutical industry, university hospitals, simulation centers, learned societies, patient associations, health professionals and the general public. Recognized as an innovative company by the Oséo Excellence 2012 network and a partner of INRIa, a digital research laboratory, the … Type: | 45 | 6 | 40 | 12 |
 | TECHNION FRANCE [Automatic translation follows] French representation of the Technion, Israel Institute Of Technology Technion France's mission is to promote the Technion, Israel Institute of Technology, in scientific, industrial and economic circles and to publicize the Technion's achievements and projects in the fields of scientific and technological research. In addition, it intends to foster the establishment of close relationships between these circles and all of the Technion's scientists, teachers and students, for the development of cooperation on projects of common interest. It also aims to increase the number of events and conferences in France by inviting specialist professors from Israel. Finally, it … Type: | 66 | 17 | 52 | 9 |
 | centdegrés Creative Activists Since 1988 We believe in bold creativity. Centdegrés is an international agency of brand intelligence and creation. Our mission is to generate value for our clients: create beautiful brands out of nothing, and render existing brands more sought after and more in tune with their era. With this in mind, we redefine their sense and redesign their shape: brand platform, visual identity, artistic direction, product design, and retail spaces. We cater to big groups, SMEs, start-ups, and international and local structures led by talents based in Paris, Dubai, Delhi, and Shanghai. As experts on beauty and perfumes, we … | 10 | 2 | 6 | 61 |
 | Kickston [Automatic translation follows] Fundraising I M&A Kickston is an investment bank that supports entrepreneurs in their fundraising and M&A operations. Industries: Consumer & Tech B2B • Fundraising: €2 to €10M • Sale: Operations up to €15M Are you interested in our approach? Contact us! contact@kickston.co Type: | 33 | 1 | 33 | 7 |
 | Arzeda The Protein Design Company (TM) - new proteins and biochemistry for the production of valuable sustainable molecules Arzeda, The Protein Design CompanyTM, is a synthetic biology company that creates novel proteins, enzymes and specialty chemical products that compete on performance, cost and sustainability. Partnering with Fortune 500 companies, Arzeda has developed a portfolio of enzymes and specialty chemicals for polymers, pharmaceuticals, industrial chemicals and other advanced applications. More information at www.arzeda.com. Synthetic Biology, Bio-based Chemicals, and Protein Design Type: | 7 | 2 | 7 | 70 |
 | Insight Media Science and research communicators. Project partners in EU-funded projects. Insight Media is a specialist communications agency focused on research and development, helping to drive knowledge transfer and create real impact for research projects. Communications, Public Relations, Scientific research, Research, Journalism, Media, Video, Dissemination, and Web development Type: | 6 | 0 | 6 | 5 |
 | ProductLife Group ProductLife Group’s mission is to improve human health by delivering regulatory compliance services for the safe and effective use of medical solutions. Since almost 30 years, PLG supports clients through the entire product life cycle, combining local expertise with global reach spanning more than 130 countries. It provides consulting and outsourcing services in the areas of regulatory affairs, quality and compliance, vigilances and medical information, covering both established products and innovative therapeutics & diagnostics. With a goal of continuously improving the value delivered to people and customers, PLG is committed to long-term partnership, innovation, flexibility, and cost efficiency. Data Management, … Type: | 9 | 4 | 6 | 1,312 |
 | Mnemo Therapeutics Empower the body, cure the disease Mnemo Therapeutics is a Paris-based biotechnology company driven to create powerful immunotherapies by improving the body’s ability to detect and eradicate cancer. The paucity of actionable cancer-specific targets creates significant challenges in the field of immuno-oncology. To address this, Mnemo has developed a combination of in-silico and wet-lab pipelines to uncover new tumour-specific targets (called E-antigens) derived from the unexploited dark genome, and to develop multiple therapeutic modalities (i.e. cell therapy, TCE, ADC, vaccine) targeting these E-antigens. Mnemo is currently pursuing several discovery campaigns for E-antigens, with a plan to develop its proprietary tumour-specific … Type: | 6 | 5 | 3 | 36 |
 | Institut de la Vision [Automatic translation follows] From the movement of knowledge to the therapeutic approaches of tomorrow Built in the heart of the Hôpital national des 15-20, the Vision Institute is one of the largest integrated research centers on vision diseases in Europe. Designed as a place of gathering and exchange, it brings together on the same site fundamental, clinical and industrial research, thus promoting the sharing of concepts and techniques, the meeting of complementary skills and expertise and the emergence of new avenues of research. Researchers, doctors and industrialists work together to discover and validate new therapies, preventive solutions, as well as … Type: | 23 | 8 | 10 | 227 |
 | Crédit Mutuel Innovation [Automatic translation follows] Our relationships bring value Crédit Mutuel Innovation is the subsidiary specializing in venture capital investments of Crédit Mutuel Equity (€4 billion in capital under management). It invests in equity tickets ranging from €1 to €20 million in innovative companies in deeptech, digital and life sciences. Crédit Mutuel Innovation allows entrepreneurs to develop their growth potential by connecting them to companies in its ecosystems. Because it takes more than 5 years to create a world leader, Crédit Mutuel Innovation invests its own capital sustainably and builds long-term relationships with the entrepreneurs it supports. Type: | 58 | 25 | 42 | 18 |
 | UI Investissement [Automatic translation follows] Together, investing for a better future A specialist in the development of unlisted French companies, UI has been committed and invested for over 50 years alongside managers of startups, SMEs and growing mid-cap companies to help economically and sustainably successful companies emerge and develop. UI Investissement manages around €1.5 billion in assets and invests with 300 managers in sectors that are essential to society, such as health, agribusiness, industry and services. Development and transmission capital, the historic core of UI's activity, represents over half of the assets under management and allows over 50 companies to benefit from … Type: | 110 | 48 | 48 | 114 |
 | CroissancePlus [Automatic translation follows] 1st French network of growth entrepreneurs, bringing together companies of all sizes and from all sectors. A network of nearly 500 entrepreneurs! Our 500 entrepreneurs are committed to building an entrepreneurial society that combines meaning and growth. A society in which each actor - civil society, associations, entrepreneurs - can create solutions to the problems encountered and meet the challenges that our society faces. Entrepreneurship, Lobbying, Entrepreneur, Networking, and Responsible Growth Type: | 64 | 18 | 44 | 93 |
 | RE:CHEMISTRY - By GFBio We make everyday products safe and sustainable. We aim to end chemical pollution in consumer products. We make everyday products safe and sustainable. We aim to end chemical pollution in consumer products by replacing harmful petro-based ingredients. Levulinic Acid, Application Development, R&D, Green Chemistry, and Formulation Development Type: | 6 | 2 | 3 | 35 |
 | MATWIN French Accelerator dedicated to innovation in oncology MATWIN (Maturation & Accelerating Translation With INdustry) est un programme accélérateur pour développer la recherche translationnelle en cancérologie et faciliter le transfert des innovations vers les patients. Son objectif principal est d'accompagner des projets innovants (issus de laboratoires académiques ou portés par des startups) et présentant un fort potentiel de développement en favorisant des partenariats précoces. Le programme s’appuie sur un partenariat avec de grands laboratoires engagés en oncologie (Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Exact Sciences, Gilead, GlaxoSmithKline, Nanostring Technologies, Novartis, Pfizer, Pierre Fabre, Roche, Sanofi) et l’ensemble des acteurs soucieux de … Type: | 71 | 19 | 62 | 7 |
SMB